Evaluation of CD33 as a genetic risk factor for Alzheimer's disease

MLA

Yuriko Katsumata, et al. “Evaluation of CD33 as a Genetic Risk Factor for Alzheimer’s Disease.” Acta Neuropathologica, vol. 138, no. 2, Feb. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....31f4ec0c1eb5bdd42863fda730950cce&authtype=sso&custid=ns315887.

APA

Yuriko Katsumata, Eileen E Press, Benjamin C. Shaw, David W. Fardo, Steven Estus, & Nicholas Devanney. (2019). Evaluation of CD33 as a genetic risk factor for Alzheimer’s disease. Acta Neuropathologica, 138(2).

Chicago

Yuriko Katsumata, Eileen E Press, Benjamin C. Shaw, David W. Fardo, Steven Estus, and Nicholas Devanney. 2019. “Evaluation of CD33 as a Genetic Risk Factor for Alzheimer’s Disease.” Acta Neuropathologica 138 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....31f4ec0c1eb5bdd42863fda730950cce&authtype=sso&custid=ns315887.